BioSight
Companies
Zai Lab Ltd logo

ZLAB

NASDAQSHANGHAI
Zai Lab Ltd

Zai Lab is a biotech company developing and commercializing drugs across oncology, autoimmune, and other therapeutic areas using small molecule and biologic modalities. The company has approved products on the market and maintains a pipeline of candidates in various clinical development stages. Zai Lab relies on third-party manufacturers and licensors to supply and develop its products and candidates.

Price history not yet available for ZLAB.

Pipeline

No pipeline data on record yet.

Catalyst Calendar

No catalyst events on record for yet. Check back after the next daily ingest.

Disclaimer·BioSight aggregates publicly available data (SEC EDGAR, ClinicalTrials.gov, FDA, company press releases) and is provided as is for informational purposes only. Nothing here is investment, financial, legal, tax, or medical advice, or an offer to buy or sell any security. We make no warranty as to accuracy, completeness, or timeliness; dates and filings may contain errors or be superseded without notice; past events do not predict future outcomes. To the maximum extent permitted by law, BioSight, its operators, contributors, and affiliates disclaim all liability for any loss or damage arising from use of or reliance on this site. You are solely responsible for your own investment decisions — consult a licensed professional before acting on any information.

Unlock 12-month calendar